Report Detail

Pharma & Healthcare Glaucoma: Competitive Landscape to 2026

  • RnM2808626
  • |
  • 24 January, 2019
  • |
  • Global
  • |
  • 48 Pages
  • |
  • GlobalData
  • |
  • Pharma & Healthcare

Glaucoma: Competitive Landscape to 2026

Summary

Glaucoma is a common, asymptomatic group of eye diseases that causes damage to the eye’s optic nerve, resulting in progressive, irreversible vision loss. Glaucoma is one of the leading causes of blindness worldwide, especially in elderly people. In glaucoma patients, the IOP-the normal healthy eye pressure that is achieved when the eye produces a small amount of aqueous humor while letting an equal amount of fluid out of the eye-is disturbed due to mechanical compression and/or decreased blood flow to the optic nerve, thereby leading to increased IOP. This increased IOP damages the optic nerve fibers that send signals from the retina to the brain, resulting in blind spots in the vision field when a significant number of nerve fibers are damaged, and blindness when the entire nerve is destroyed. The exact cause of optic nerve damage from glaucoma is not yet clearly.

This report provides an assessment of the pipeline, clinical, and commercial landscape of Glaucoma. Overall, GlobalData expects new drug approvals to drive Glaucoma market growth over the next decade (2016-2026).

Scope

- Pipeline Assessment: regional breakdown, promising late-stage products, early-stage pipeline by molecule type
- Clinical Trials Assessment: trial breakdown by phase, leading industry and non-industry sponsors, enrollment analytics
- Commercial Assessment: leading marketed products, current and future players
- Competitive Landscape: Analysis-key market events (2016-2026).

Reasons to buy

- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the global Glaucoma market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Glaucoma market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.


Table of Contents

    1. Preface 2

    • 1.1 Table of Contents 2
    • 1.2 Abbreviations 3
    • 1.3 Related Reports 4

    2. Executive Summary 5

    • 2.2 Key Findings 6
    • 2.2 Key Events 7

    3. Introduction 8

    • 3.1 Report Scope 9-10
    • 3.2 Disease Overview and Epidemiology 11-13

    4. Pipeline Assessment 14

    • 4.1 Pipeline Overview 15-16
    • 4.2 Pipeline Breakdown by Region/Country 17
    • 4.3 Pipeline Breakdown by Molecule Type and Target 18
    • 4.4 Drug Review Designations 19
    • 4.5 Products in Clinical Development 20-21

    5. Clinical Trial Assessment 22

    • 5.1 Clinical Trials Overview 23
    • 5.2 Top Sponsors of Clinical Trials in Glaucoma 24-25
    • 5.3 Trial Breakdown by Region 26
    • 5.4 Therapy Area Perspective 27
    • 5.5 Enrollment Analytics 28-30

    6 Commercial Assessment 31

    • 6.1 Leading Marketed Products 32
    • 6.2 Current & Future Players 33

    7. Competitive Landscape Analysis (2016-2026) 34

    • 7.1 Events Classification Overview 35
    • 7.2 US 36
    • 7.3 5EU 37
    • 7.4 Japan and China 38

    8 Appendix 39

    • 8.1 Sources 40
    • 8.2 Methodology 41
    • 8.3 Key Events Included in the Analysis 42
    • 8.4 About the Authors 43-45
    • 8.5 About GlobalData 46

    Summary:
    Get latest Market Research Reports on Glaucoma: Competitive Landscape to 2026. Industry analysis & Market Report on Glaucoma: Competitive Landscape to 2026 is a syndicated market report, published as Glaucoma: Competitive Landscape to 2026. It is complete Research Study and Industry Analysis of Glaucoma: Competitive Landscape to 2026 market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,495.00
    $6,990.00
    $10,485.00
    2,764.55
    5,529.09
    8,293.64
    3,222.39
    6,444.78
    9,667.17
    542,773.50
    1,085,547.00
    1,628,320.50
    291,832.50
    583,665.00
    875,497.50
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report